RNA interference as a gene knockdown technique

International Journal of Biochemistry and Cell Biology

Volumn 42, Issue 8, 2010, Pages 1243-1251

  Shan, Ge ^a  

^a YALE UNIVERSITY   (United States)

Author keywords

EGS; Morpholino; RNA interference (RNAi); Systematic; Therapeutics

Indexed keywords

DOUBLE STRANDED RNA; EXONUCLEASE; LIPOPLEX; LIPOSOME; NUCLEOTIDE; PHOSPHOLIPID; PLASMID VECTOR; RNA POLYMERASE II; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; SULFUR; TOLL LIKE RECEPTOR;

CAENORHABDITIS ELEGANS; CELL MEMBRANE; CYTOPLASM; DROSOPHILA; ENZYME DEGRADATION; EUKARYOTE; GENE EXPRESSION; GENE SILENCING; GENOME; IN VIVO STUDY; MAMMAL CELL; NERVE CELL; NONHUMAN; PROKARYOTE; REVIEW; RNA INTERFERENCE; ANIMAL; CELL CULTURE; HUMAN; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PROCEDURES;

ANIMALS; BASE SEQUENCE; CELLS, CULTURED; GENE KNOCKDOWN TECHNIQUES; HUMANS; MOLECULAR SEQUENCE DATA; RNA INTERFERENCE; RNA, SMALL INTERFERING;

ANIMALIA;

EID: 77954386712     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2009.04.023     Document Type: Review

References (143)

1. Abbas-Terki T., Blanco-Bose W., Déglon N., Pralong W., Aebischer P. Lentiviral-mediated RNA interference. Hum Gene Ther 2002, 13(18):2197-2201.
2. Alemán L.M., Doench J., Sharp P.A. Comparison of siRNA-induced off-target RNA and protein effects. RNA 2007, 13(3):385-395.
3. Allerson C.R., Sioufi N., Jarres R., Prakash T.P., Naik N., Berdeja A., et al. Fully 2'-modified oligonucleotide duplexes with improved in vitro potency and stability compared to unmodified small interfering RNA. J Med Chem 2005, 48:901-904.
4. Altman S. A view of RNase. Mol Biosyst 2007, 3(9):604-607.
5. Ashrafi K., Chang F.Y., Watts J.L., Fraser A.G., Kamath R.S., Ahringer J., et al. Genome-wide RNAi analysis of Caenorhabditis elegans fat regulatory genes. Nature 2003, 421(6920):268-272.
6. Bai Y., Trang P., Li H., Kim K., Zhou T., Liu F. Effective inhibition in animals of viral pathogenesis by a ribozyme derived from RNase P catalytic RNA. Proc Natl Acad Sci USA 2008, 105(31):10919-10924.
7. Bassett T., Harpur B., Poon H.Y., Kuo K.H., Lee C.H. Effective stimulation of growth in MCF-7 human breast cancer cells by inhibition of syntaxin18 by external guide sequence and ribonuclease. Cancer Lett 2008, [Epub ahead of print].
8. Bauer M., Ueffing M. Reverse genetics for proteomics: from proteomic discovery to scientific content. J Neural Transm 2006, 113(8):1033-1040.
9. Baulcombe D. RNA silencing in plants. Nature 2004, 431:356-363.
10. Birmingham A., Anderson E.M., Reynolds A., Ilsley-Tyree D., Leake D., Fedorov Y., et al. 3'UTR seed matches, but not overall identity, are associated with RNAi off-targets. Nat Methods 2006, 3:199-204.
11. Bitko V., Musiyenko A., Shulyayeva O., Barik S. Inhibition of respiratory viruses by nasally administered siRNA. Nat Med 2005, 11:50-55.
12. Björklund M., Taipale M., Varjosalo M., Saharinen J., Lahdenperä J., Taipale J. Identification of pathways regulating cell size and cell-cycle progression by RNAi. Nature 2006, 439(7079):1009-1013.
13. Bonaldi T., Straub T., Cox J., Kumar C., Becker P.B., Mann M. Combined use of RNAi and quantitative proteomics to study gene function in Drosophila. Mol Cell 2008, 31(5):762-772.
14. Bondensgaard K., Petersen M., Singh S.K., Rajwanshi V.K., Kumar R., Wengel J., et al. Structural studies of LNA:RNA duplexes by NMR: conformations and implications for RNaseH activity. Chemistry (Easton) 2000, 6:2687-2695.
15. Boutros M., Kiger A.A., Armknecht S., Kerr K., Hild M., Koch B., et al. Genome-wide RNAi analysis of growth and viability in Drosophila cells. Science 2004, 303(5659):832-835.
16. Braasch D.A., Corey D.R. Locked nucleic acid (LNA): fine-tuning the recognition of DNA and RNA. Chem Biol 2001, 8:1-7.
17. Caplen N.J., Fleenor J., Fire A., Morgan R.A. dsRNA-mediated gene silencing in cultured Drosophila cells: a tissue culture model for the analysis of RNA interference. Gene 2000, 252:95-105.
18. Cauchi R.J., Davies K.E., Liu J.L. A motor function for the DEAD-box RNA helicase, Gemin3, in Drosophila. PLoS Genet 2008, 4(11):e1000265.
19. Chang C.I., Yoo J.W., Hong S.W., Lee S.E., Kang H.S., Sun X., et al. Asymmetric shorter-duplex siRNA structures trigger efficient gene silencing with reduced nonspecific effects. Mol Ther 2009, [Epub ahead of print].
20. Chang K., Elledge S.J., Hannon G.J. Lessons from nature: microRNA-based shRNA libraries. Nat Methods 2006, 3(9):707-714.
21. Cherry S. Genomic RNAi screening in Drosophila S2 cells: what have we learned about host-pathogen interactions?. Curr Opin Microbiol 2008, 11(3):262-270.
22. Chiu Y.L., Rana T.M. siRNA function in RNAi: a chemical modification analysis. RNA 2003, 9:1034-1048.
23. Choung S., Kim Y.J., Kim S., Park H.O., Choi Y.C. Chemical modification of siRNAs to improve serum stability without loss of efficacy. Biochem Biophys Res Commun 2006, 342:919-927.
24. Clemens J.C., Worby C.A., Simonson-Leff N., Muda M., Maehama T., Hemmings B.A., et al. Use of double-stranded RNA interference in Drosophila cell lines to dissect signal transduction pathways. Proc Natl Acad Sci USA 2000, 97(12):6499-6503.
25. Corey D.R. Chemical modification: the key to clinical application of RNA interference?. J Clin Invest 2007, 117(12):3615-3622.
26. DasGupta R., Gonsalves F.C. High-throughput RNAi screen in Drosophila. Methods Mol Biol 2008, 469:163-184.
27. Davidson T.J., Harel S., Arboleda V.A., Prunell G.F., Shelanski M.L., Greene L.A., et al. Highly efficient small interfering RNA delivery to primary mammalian neurons induces micro-RNA-like effects before mRNA degradation. J Neurosci 2004, 24:10040-10046.
28. de Fougerolles A., Manoharan M., Meyers R., Vornlocher H.P. RNA interference in vivo: toward synthetic small inhibitory RNA-based therapeutics. Methods Enzymol 2005, 392:278-296.
29. de Fougerolles A.R. Delivery vehicles for small interfering RNA in vivo. Hum Gene Ther 2008, 19(2):125-132.
30. Dietzl G., Chen D., Schnorrer F., Su K.C., Barinova Y., Fellner M., et al. A genome-wide transgenic RNAi library for conditional gene inactivation in Drosophila. Nature 2007, 448(7150):151-156.
31. Dorn G., Patel S., Wotherspoon G., Hemmings-Mieszczak M., Barclay J., Natt F.J., et al. siRNA relieves chronic neuropathic pain. Nucleic Acids Res 2004, 32:e49.
32. Eckstein F. The versatility of oligonucleotides as potential therapeutics. Expert Opin Biol Ther 2007, 7(7):1021-1034.
33. Elbashir S.M., Harborth J., Lendeckel W., Yalcin A., Weber K., Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001, 411(6836):494-498.
34. Elbashir S.M., Lendeckel W., Tuschl T. RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev 2001, 15(2):188-200.
35. Faria M., Ulrich H. Sugar boost: when ribose modifications improve oligonucleotide performance. Curr Opin Mol Ther 2008, 10(2):168-175.
36. Fedorov Y., Anderson E.M., Birmingham A., Reynolds A., Karpilow J., Robinson K., et al. Off-target effects by siRNA can induce toxic phenotype. RNA 2006, 12:1188-1196.
37. Fewell G.D., Schmitt K. Vector-based RNAi approaches for stable, inducible and genome-wide screens. Drug Discov Today 2006, 11(21-22):975-982.
38. Fire A., Xu S., Montgomery M.K., Kostas S.A., Driver S.E., Mello C.C. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998, 391(6669):806-811.
39. Fleming S.L., Rieder C.L. Flattening Drosophila cells for high-resolution light microscopic studies of mitosis in vitro. Cell Motil Cytoskeleton 2003, 56(3):141-146.
40. Flynt A.S., Li N., Thatcher E.J., Solnica-Krezel L., Patton J.G. Zebrafish miR-214 modulates Hedgehog signaling to specify muscle cell fate. Nat Genet 2007, 39(2):259-263.
41. Fu D., Uauy C., Blechl A., Dubcovsky J. RNA interference for wheat functional gene analysis. Transgenic Res 2007, 16(6):689-701.
42. Ganesan A.K., Ho H., Bodemann B., Petersen S., Aruri J., Koshy S., et al. Genome-wide siRNA-based functional genomics of pigmentation identifies novel genes and pathways that impact melanogenesis in human cells. PLoS Genet 2008, 4(12):e1000298.
43. Ge Q., Filip L., Bai A., Nguyen T., Eisen H.N., Chen J. Inhibition of influenza virus production in virus-infected mice by RNA interference. Proc Natl Acad Sci USA 2004, 101:8676-8681.
44. Gitlin L., Karelsky S., Andino R. Short interfering RNA confers intracellular antiviral immunity in human cells. Nature 2002, 418(6896):430-434.
45. Grimm D., Streetz K.L., Jopling C.L., Storm T.A., Pandey K., Davis C.R., et al. Fatality in mice due to over saturation of cellular microRNA/short hairpin RNA pathways. Nature 2006, 441:537-541.
46. Grzelinski M., Urban-Klein B., Martens T., Lamszus K., Bakowsky U., Höbel S., et al. RNA interference-mediated gene silencing of pleiotrophin through polyethylenimine-complexed small interfering RNAs in vivo exerts antitumoral effects in glioblastoma xenografts. Hum Gene Ther 2006, 17:751-766.
47. Hao L., Sakurai A., Watanabe T., Sorensen E., Nidom C.A., Newton M.A., et al. Drosophila RNAi screen identifies host genes important for influenza virus replication. Nature 2008, 454(7206):890-893.
48. Haussecker D. The business of RNAi therapeutics. Hum Gene Ther 2008, 19(5):451-462.
49. Heasman J. Morpholino oligos: making sense of antisense?. Dev Biol 2002, 243(2):209-214.
50. Hornung V., Guenthner-Biller M., Bourquin C., Ablasser A., Schlee M., Uematsu S., et al. Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat Med 2005, 11(3):263-270.
51. Howard K.A., Kjems J. Polycation-based nanoparticle delivery for improved RNA interference therapeutics. Expert Opin Biol Ther 2007, 7(12):1811-1822.
52. Jackson A.L., Bartz S.R., Schelter J., Kobayashi S.V., Burchard J., Mao M., et al. Expression profiling reveals offtarget gene regulation by RNAi. Nat Biotechnol 2003, 21:635-637.
53. Jackson A.L., Burchard J., Leake D., Reynolds A., Schelter J., Guo J., et al. Position-specific chemical modification of siRNAs reduces off-target transcript silencing. RNA 2006, 12:1197-1205.
54. Judge A.D., Sood V., Shaw J.R., Fang D., McClintock K., MacLachlan I. Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA. Nat Biotechnol 2005, 23:457-462.
55. Juliano R., Alam M.R., Dixit V., Kang H. Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides. Nucleic Acids Res 2008, 36(12):4158-4171.
56. Kamath R.S., Martinez-Campos M., Zipperlen P., Fraser A.G., Ahringer J. Effectiveness of specific RNA-mediated interference through ingested double-stranded RNA in Caenorhabditis elegans. Genome Biol 2001, 2(1). RESEARCH0002.
57. Kennedy S., Wang D., Ruvkun G. A conserved siRNA-degrading RNase negatively regulates RNA interference in C. elegans. Nature 2004, 427(6975):645-649.
58. Khvorova A., Reynolds A., Jayasena S.D. Functional siRNAs and miRNAs exhibit strand bias. Cell 2003, 115:209-216.
59. Kim J.K., Gabel H.W., Kamath R.S., Tewari M., Pasquinelli A., Rual J.F., et al. Functional genomic analysis of RNA interference in C. elegans. Science 2005, 308(5725):1164-1167.
60. Kim W.J., Christensen L.V., Jo S., Yockman J.W., Jeong J.H., Kim Y.H., et al. Cholesteryl oligoarginine delivering vascular endothelial growth factor siRNA effectively inhibits tumor growth in colon adenocarcinoma. Mol Ther 2006, 14:343-350.
61. Kittler R., Pelletier L., Heninger A.K., Slabicki M., Theis M., Miroslaw L., et al. Genome-scale RNAi profiling of cell division in human tissue culture cells. Nat Cell Biol 2007, 9(12):1401-1412.
62. Kittler R., Pelletier L., Buchholz F. Systems biology of mammalian cell division. Cell Cycle 2008, 7(14):2123-2128.
63. Ko J.H., Izadjoo M., Altman S. Inhibition of expression of virulence genes of Yersinia pestis in Escherichia coli by external guide sequences and RNase. RNA 2008, 14(8):1656-1662.
64. König R., Chiang C.Y., Tu B.P., Yan S.F., DeJesus P.D., Romero A., et al. A probability-based approach for the analysis of large-scale RNAi screens. Nat Methods 2007, 4(10):847-849.
65. Krausz E. High-content siRNA screening. Mol Biosyst 2007, 3(4):232-240.
66. Kubo T., Zhelev Z., Ohba H., Bakalova R. Modified 27-nt dsRNAs with dramatically enhanced stability in serum and long-term RNAi activity. Oligonucleotides 2007, 17(4):445-464.
67. Kumar P., Lee S.K., Shankar P., Manjunath N. A single siRNA suppresses fatal encephalitis induced by two different flaviviruses. PLoS Med 2006, 3:505-514.
68. Kumar P., Wu H., McBride J.L., Jung K.E., Kim M.H., Davidson B.L., et al. Transvascular delivery of small interfering RNA to the central nervous system. Nature 2007, 448(7149):39-43.
69. Kunath T., Gish G., Lickert H., Jones N., Pawson T., Rossant J. Transgenic RNA interference in ES cell-derived embryos recapitulates a genetic null phenotype. Nat Biotechnol 2003, 21(5):559-561.
70. Kuttenkeuler D., Boutros M. Genome-wide RNAi as a route to gene function in Drosophila. Brief Funct Genomic Proteomic 2004, 3(2):168-176.
71. Lai E.C. Micro RNAs are complementary to 3' UTR sequence motifs that mediate negative post-transcriptional regulation. Nat Genet 2002, 30(4):363-364.
72. Layzer J.M., McCaffrey A.P., Tanner A.K., Huang Z., Kay M.A., Sullenger B.A. In vivo activity of nuclease-resistant siRNAs. RNA 2004, 10:766-771.
73. Lee R.C., Feinbaum R.L., Ambros V., The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993, 75(5):843-854.
74. Lee S.S. Whole genome RNAi screens for increased longevity: important new insights but not the whole story. Exp Gerontol 2006, 41(10):968-973.
75. Leirdal M., Sioud M. Gene silencing in mammalian cells by preformed small RNA duplexes. Biochem Biophys Res Commun 2002, 295(3):744-748.
76. Lents N.H., Baldassare J.J. RNA interference takes flight: a new RNAi screen reveals cell cycle regulators in Drosophila cells. Trends Endocrinol Metab 2006, 17(5):173-174.
77. Li Y., Guerrier-Takada C., Altman S. Targeted cleavage of mRNA in vitro by RNase P from Escherichia coli. Proc Natl Acad Sci USA 1992, 89(8):3185-3189.
78. Lin X., Ruan X., Anderson M.G., McDowell J.A., Kroeger P.E., Fesik S.W., et al. siRNA-mediated off-target gene silencing triggered by a 7 nt complementation. Nucleic Acids Res 2005, 33:4527-4535.
79. Liu X., Davis R.L. The GABAergic anterior paired lateral neuron suppresses and is suppressed by olfactory learning. Nat Neurosci 2009, 12(1):53-59.
80. Lundblad E.W., Xiao G., Ko J.H., Altman S. Rapid selection of accessible and cleavable sites in RNA by Escherichia coli RNase P and random external guide sequences. Proc Natl Acad Sci USA 2008, 105(7):2354-2357.
81. Luo M.C., Zhang D.Q., Ma S.W., Huang Y.Y., Shuster S.J., Porreca F., et al. An efficient intrathecal delivery of small interfering RNA to the spinal cord and peripheral neurons. Mol Pain 2005, 1:29.
82. Ma M., Benimetskaya L., Lebedeva I., Dignam J., Takle G., Stein C.A. Intracellular mRNA cleavage induced through activation of RNase P by nuclease-resistant external guide sequences. Nat Biotechnol 2000, 18(1):58-61.
83. Mabon M.E., Mao X., Jiao Y., Scott B.A., Crowder C.M. Systematic identification of gene activities promoting hypoxic death. Genetics 2008, [Epub ahead of print].
84. Mattila J., Kallijärvi J., Puig O. RNAi screening for kinases and phosphatases identifies FoxO regulators. Proc Natl Acad Sci USA 2008, 105(39):14873-14878.
85. McNamara J.O., Andrechek E.R., Wang Y., Viles K.D., Rempel R.E., Gilboa E., et al. Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras. Nat Biotechnol 2006, 24:1005-1015.
86. Minks M.A., West D.K., Benvin S., Baglioni C. Structural requirements of double-stranded RNA for the activation of 2',5'-oligo(A) polymerase and protein kinase of interferon-treated HeLa cells. J Biol Chem 1979, 254:10180-10183.
87. Miyawaki-Shimizu K., Predescu D., Shimizu J., Broman M., Predescu S., Malik A.B. siRNA-induced caveolin-1 knockdown in mice increases lung vascular permeability via the junctional pathway. Am J Physiol Lung Cell Mol Physiol 2006, 290:L405-L413.
88. Moghimi S.M., Hunter A.C., Murray J.C. Nanomedicine: current status and future prospects. FASEB J 2005, 19(3):311-330.
89. Montgomery M.K., Xu S., Fire A. RNA as a target of double-stranded RNA-mediated genetic interference in Caenorhabditis elegans. Proc Natl Acad Sci USA 1998, 95(26):15502-15507.
90. Murchison E., Hannon G.J. miRNAs on the move: miRNA biogenesis and the RNAi machinery. Curr Opin Cell Biol 2004, 16(3):223-229.
91. Naito Y., Yamada T., Matsumiya T., Ui-Tei K., Saigo K., Morishita S. dsCheck: highly sensitive off-target search software for double stranded RNA-mediated RNA interference. Nucleic Acids Res 2005, 33(Web Server issue):W589-W591.
92. Nakamura H., Siddiqui S.S., Shen X., Malik A.B., Pulido J.S., Kumar N.M., et al. RNA interference targeting transforming growth factor-beta type II receptor suppresses ocular inflammation and fibrosis. Mol Vision 2004, 10:703-711.
93. Okamura K., Hagen J.W., Duan H., Tyler D.M., Lai E.C. The mirtron pathway generates microRNA-class regulatory RNAs in Drosophila. Cell 2007, 130(1):89-100.
94. Paddison J. RNA interference in mammalian cell systems. Curr Top Microbiol Immunol 2008, 320:1-19.
95. Parry D.H., Xu J., Ruvkun G. A whole-genome RNAi Screen for C. elegans miRNA pathway genes. Curr Biol 2007, 17(23):2013-2022.
96. Pei Y., Tuschl T. On the art of identifying effective and specific siRNAs. Nat Methods 2006, 3:670-676.
97. Persengiev S.P., Zhu X., Green M.R. Nonspecific, concentration-dependent stimulation and repression of mammalian gene expression by small interfering RNAs (siRNAs). RNA 2004, 10(1):12-18.
98. Preall J.B., Sontheimer E.J. RNAi: RISC gets loaded. Cell 2005, 123(4):543-545.
99. Qiu S., Adema C.M., Lane T. A computational study of off-target effects of RNA interference. Nucleic Acids Res 2005, 33:1834-1847.
100. Que-Gewirth N.S., Sullenger B.A. Gene therapy progress and prospects: RNA aptamers. Gene Ther 2007, 14(4):283-291.
101. Reich S.J., Fosnot J., Kuroki A., Tang W., Yang X., Maguire A.M., et al. Small interfering RNA(siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model. Mol Vision 2003, 9:210-216.
102. Reyes-Darias J.A., Sánchez-Luque F.J., Berzal-Herranz A. Inhibition of HIV-1 replication by RNA-based strategies. Curr HIV Res 2008, 6(6):500-514.
103. Reynolds A., Leake D., Boese Q., Scaringe S., Marshall W.S., Khvorova A. Rational siRNA design for RNA interference. Nat Biotechnol 2004, 22:326-330.
104. Rinn J.L., Kertesz M., Wang J.K., Squazzo S.L., Xu X., Brugmann S.A., et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 2007, 129(7):1311-1323.
105. Root D.E., Hacohen N., Hahn W.C., Lander E.S., Sabatini D.M. Genome-scale loss-of-function screening with a lentiviral RNAi library. Nat Methods 2006, 3(9):715-719.
106. Ruby J.G., Jan C.H., Bartel D.P. Intronic microRNA precursors that bypass Drosha processing. Nature 2007, 448(7149):83-86.
107. Samuelson A.V., Klimczak R.R., Thompson D.B., Carr C.E., Ruvkun G. Identification of Caenorhabditis elegans genes regulating longevity using enhanced RNAi-sensitive strains. Cold Spring Harb Symp Quant Biol 2007, 72:489-497.
108. Schiffelers R.M., Ansari A., Xu J., Zhou Q., Tang Q., Storm G., et al. Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle. Nucleic Acids Res 2004, 32:e149.
109. Schlee M., Hornung V., Hartmann G. siRNA and isRNA: two edges of one sword. Mol Ther 2006, 14:463-470.
110. Schwarz D.S., Ding H., Kennington L., Moore J.T., Schelter J., Burchard J., et al. Designing siRNA that distinguish between genes that differ by a single nucleotide. PLoS Genetics 2006, 2:1307-1318.
111. Selbach M., Mann M. Protein interaction screening by quantitative immunoprecipitation combined with knockdown (QUICK). Nat Methods 2006, 3(12):981-983.
112. Shan G., Jin P. RNA interference to treat human diseases. Wiley encyclopedia of chemical biology 2009, vol. 4:241-251. John Wiley & Sons, Hoboken.
113. Shan G., Walthall W.W. Copulation in C. elegans males requires a nuclear hormone receptor. Dev Biol 2008, 322(1):11-20.
114. Shan G., Li Y., Zhang J., Li W., Szulwach K.E., Duan R., et al. A small molecule enhances RNA interference and promotes microRNA processing. Nat Biotechnol 2008, 26(8):933-940.
115. Simeoni F., Morris M.C., Heitz F., Divita G. Insight into the mechanism of the peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cells. Nucleic Acids Res 2003, 31:2717-2724.
116. Simmer F., Moorman C., van der Linden A.M., Kuijk E., van den Berghe P.V., Kamath R.S., et al. Genome-wide RNAi of C. elegans using the hypersensitive rrf-3 strain reveals novel gene functions. PLoS Biol 2003, 1(1):E12.
117. Simmer F., Tijsterman M., Parrish S., Koushika S.P., Nonet M.L., Fire A., et al. Loss of the putative RNA-directed RNA polymerase RRF-3 makes C. elegans hypersensitive to RNAi. Curr Biol 2002, 12(15):1317-1319.
118. Sioud M. Does the understanding of immune activation by RNA predict the design of safe siRNAs?. Front Biosci 2008, 13:4379-4392.
119. Sledz C.A., Holko M., de Veer M.J., Silverman R.H., Williams B.R. Activation of the interferon system by short-interfering RNAs. Nat Cell Biol 2003, 5(9):834-839.
120. Song E., Zhu P., Lee S.K., Chowdhury D., Kussman S., Dykxhoorn D.M., et al. Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors. Nat Biotechnol 2005, 23:709-717.
121. Sørensen D.R., Leirdal M., Sioud M. Gene silencing by systemic delivery of synthetic siRNAs in adult mice. J Mol Biol 2003, 327(4):761-766.
122. Stark G.R., Kerr I.M., Williams B.R., Silverman R.H., Schreiber R.D. How cells respond to interferons. Annu Rev Biochem 1998, 67:227-264.
123. Summerton J.E. Morpholino, siRNA, and S-DNA compared: impact of structure and mechanism of action on off-target effects and sequence specificity. Curr Top Med Chem 2007, 7(7):651-660.
124. Sun X., Rogoff H.A., Li C.J. Asymmetric RNA duplexes mediate RNA interference in mammalian cells. Nat Biotechnol 2008, 26(12):1379-1382.
125. Tabara H., Grishok A., Mello C.C. RNAi in C. elegans: soaking in the genome sequence. Science 1998, 282(5388):430-431.
126. Tan P.H., Yang L.C., Shih H.C., Lan K.C., Cheng J.T. Gene knock down with intrathecal siRNA of NMDA receptor NR2B subunit reduces formalin-induced nociception in the rat. Gene Ther 2005, 12:59-66.
127. Tavernarakis N., Wang S.L., Dorovkov M., Ryazanov A., Driscoll M. Heritable and inducible genetic interference by double-stranded RNA encoded by transgenes. Nat Genet 2000, 24(2):180-183.
128. Timmons L., Fire A. Specific interference by ingested dsRNA. Nature 1998, 395(6705):854.
129. Travella S., Klimm T.E., Keller B. RNA interference-based gene silencing as an efficient tool for functional genomics in hexaploid bread wheat. Plant Physiol 2006, 142:6-20.
130. Turner J.J., Jones S., Fabani M.M., Ivanova G., Arzumanov A.A., Gait M.J. RNA targeting with peptide conjugates of oligonucleotides, siRNA and PNA. Blood Cells Mol Dis 2007, 38(1):1-7.
131. Uematsu S., Akira S. Toll-like receptors and Type I interferons. J Biol Chem 2007, 282(21):15319-15323.
132. Ui-Tei K., Zenno S., Miyata Y., Saigo K. Sensitive assay of RNA interference in Drosophila and Chinese hamster cultured cells using firefly luciferase gene as target. FEBS Lett 2000, 479:79-82.
133. Ulvila J., Parikka M., Kleino A., Sormunen R., Ezekowitz R.A., Kocks C., et al. Double-stranded RNA is internalized by scavenger receptor-mediated endocytosis in Drosophila S2 cells. J Biol Chem 2006, 281(20):14370-14375.
134. Urban-Klein B., Werth S., Abuharbeid S., Czubayko F., Aigner A. RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo. Gene Ther 2005, 12:461-466.
135. Wang D., Kennedy S., Conte D., Kim J.K., Gabel H.W., Kamath R.S., et al. Somatic misexpression of germline P granules and enhanced RNA interference in retinoblastoma pathway mutants. Nature 2005, 436(7050):593-597.
136. Watts J.K., Deleavey G.F., Damha M.J. Chemically modified siRNA: tools and applications. Drug Discov Today 2008, 13(19/20):842-855.
137. Wightman B., Ha I., Ruvkun G. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 1993, 75(5):855-862.
138. Yuan Y., Altman S. Selection of guide sequences that direct efficient cleavage of mRNA by human ribonuclease. Science 1994, 263(5151):1269-1273.
139. Zamore P.D., Tuschl T., Sharp P.A., Bartel D.P. RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell 2000, 101(1):25-33.
140. Zender L., Xue W., Zuber J., Semighini C.P., Krasnitz A., Ma B., et al. An oncogenomics-based in vivo RNAi screen identifies tumor suppressors in liver cancer. Cell 2008, 135(5):852-864.
141. Zhang X., Shan P., Jiang D., Noble P.W., Abraham N.G., Kappas A., et al. Small interfering RNA targeting hemeoxygenase-1 enhances ischemia-reperfusion-induced lung apoptosis. J Biol Chem 2004, 279:10677-10684.
142. Zhou H., Xu M., Huang Q., Gates A.T., Zhang X.D., Castle J.C., et al. Genome-scale RNAi screen for host factors required for HIV replication. Cell Host Microbe 2008, 4(5):495-504.
143. Zitzmann S., Ehemann V., Schwab M. Arginine-glycine-aspartic acid (RGD)-peptide binds to both tumor and tumor-endothelial cells in vivo. Cancer Res 2002, 62(18):5139-5143.